[Measles vaccination].
D000276:Adjuvants, Immunologic; D000354:Africa, Western; D000367:Age Factors; D000917:Antibody Formation; D002493:Central Nervous System Diseases / Q000209:etiology; D002675:Child, Preschool; D004673:Encephalomyelitis, Acute Disseminated; D004739:England; D004812:Epidemiologic Methods; D005860:Germany, West; D006801:Humans; D007117:Immunization, Secondary; D007223:Infant; D008457:Measles / Q000453:epidemiology / Q000276:immunology / Q000401:mortality / Q000517:prevention & control*; D008458:Measles Vaccine / Q000008:administration & dosage / Q000009:adverse effects; D008459:Measles virus / Q000472:pathogenicity; D014481:United States; D014611:Vaccination; D014613:Vaccines, Attenuated
D000276:Adjuvants, Immunologic; D008458:Measles Vaccine; D014613:Vaccines, Attenuated
Masernschutzimpfungen.